SCHEMBL21414378

SCHEMBL21414378

CCC(C)c1ccc(CN2CCN(CC)CC2)cn1

nearest known ligand 0.49

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.49
▸ CCND1 P24385 9/20 0.43
▸ CDK6 Q00534 5/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ TP53 P04637 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ CDK4 P11802 7/20 0.41
▸ TSHR P16473 1/20 0.41
▸ ATM Q13315 1/20 0.41
▸ CDK1 P06493 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21414385 0.90 LMNA (0.46) ALDH1A1NPC1MEN1KMT2AKDM4E
SCHEMBL20203451 0.88 ALDH1A1 (0.51) ALDH1A1CCND1CDK6NPC1MEN1
SCHEMBL21414349 0.86 ALDH1A1 (0.50) ALDH1A1NPC1MEN1KMT2AKDM4E
SCHEMBL21414369 0.86 CXCR4 (0.44) CCND1CDK6MEN1KMT2ACDK4
SCHEMBL21414381 0.81 HRH3 (0.47) ALDH1A1MEN1KMT2ARAB9AATM
SCHEMBL21414453 0.80 CHEK1 (0.41) ALDH1A1MEN1KMT2ATP53SMN1; SMN2
SCHEMBL21414345 0.80 KMT2A (0.41) ALDH1A1MEN1KMT2ATP53SMN1; SMN2
SCHEMBL23108706 0.78 LMNA (0.46) ALDH1A1NPC1MEN1KMT2AKDM4E
SCHEMBL1666554 0.76 ALDH1A1 (0.61) ALDH1A1NPC1MEN1KMT2AKDM4E
SCHEMBL17660303 0.76 LMNA (0.50) ALDH1A1NPC1MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3546458-B1 ((PYRIDIN-2-YL)-AMINO)PYRIDO[3,4-D]PYRIMIDINE AND ((PYRIDAZIN-3-YL)-AMINO)PYRIDO[3,4-D]PYRIMIDINE DERIVATIVES AS CDK4/6 INHIBITORS FOR TREATING E.G. RHEUMATOID ARTHRITIS, ARTERIOSCLEROSIS, PULMONARY FIBROSIS, CEREBRAL INFARCTION OR CANCER TEIJIN PHARMA LTD (JP) 2021-01-06 — — EP disclosed
EP-3546458-A1 PYRIDO[3, 4-D]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF Teijin Pharma Limited (JP) 2019-10-02 — — EP disclosed
Send feedback